DaVita Inc. (DVA) Earnings Call Analysis

NYSE · Healthcare · Medical Care Facilities

9/25

Growth 1 Margin 0 Expansion 4 Platform 0 Financial 4

latest quarter score

Earnings Reports

9
DaVita (DVA) Q2 2026: Commercial Mix Declines Drive $40M Headwind, Margin Leverage Under Pressure
August 05, 2026
16
DaVita (DVA) Q1 2026: Technology-Driven G&A Up 13% as Volume Outlook Improves
June 17, 2026
17
DaVita (DVA) Q4 2025: IKC Turns Profitable, $20M Growth Target Signals Value-Based Care Maturity
June 15, 2026
12
DaVita (DVA) Q3 2025: Volume Decline Hits 1.5% as Mix, Policy, and Tech Spend Drive 2026 Uncertainty
October 30, 2025
14
DaVita (DVA) Q2 2025: Cost Controls Offset -1% U.S. Treatment Decline as Mortality Remains Elevated
August 06, 2025
16
DaVita (DVA) Q1 2025: $680M Share Buybacks Front-Loaded as Cyber, Volume Headwinds Offset Binder Upside
July 06, 2025

Browse all companies